Reported Reactions

Devices › Prosthesis, breast, noninflatable, internal, silicone gel-filled

Device brand name · Prosthesis breast noninflatable internal silicone gel-filled

Inspira Smooth Cohesive Silicone Gel Filled Breast Implant: medical device reports filed with FDA

4,636 reports name it, 2019–2026. Manufacturer given most often on reports: Allergan Costa Rica. Product code FTR.

4,636
device reports naming the brand
0% of all MAUDE reports · about 647 a year
1,076
reports, 12 months to August 2026
780 in the 12 months before
2.3%
classified as malfunction
1.6% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

4,636 medical device reports received by FDA name the brand "Inspira Smooth Cohesive Silicone Gel Filled Breast Implant" (prosthesis breast noninflatable internal silicone gel-filled); the manufacturer given most often on reports is Allergan Costa Rica; received from May 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

1,076 reports arrived in the 12 months to August 2026, up 38% from 780 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (97.7%) and malfunction (2.3%); across all prosthesis, breast, noninflatable, internal, silicone gel-filled reports (product code FTR) death is recorded in 0.1% and malfunction in 1.6%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are device appears to trigger rejection (60%), material rupture (13.5%) and patient-device incompatibility (11.6%). The patient problems coded most often are capsular contracture, failure of implant and seroma. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

067133Sep 2021: 12Oct 2021: 24Nov 2021: 59Dec 2021: 702022Jan 2022: 60Feb 2022: 31Mar 2022: 47Apr 2022: 57May 2022: 63Jun 2022: 59Jul 2022: 55Aug 2022: 61Sep 2022: 53Oct 2022: 57Nov 2022: 67Dec 2022: 632023Jan 2023: 60Feb 2023: 32Mar 2023: 42Apr 2023: 58May 2023: 56Jun 2023: 53Jul 2023: 46Aug 2023: 42Sep 2023: 52Oct 2023: 56Nov 2023: 50Dec 2023: 352024Jan 2024: 62Feb 2024: 49Mar 2024: 55Apr 2024: 64May 2024: 50Jun 2024: 68Jul 2024: 70Aug 2024: 68Sep 2024: 58Oct 2024: 75Nov 2024: 70Dec 2024: 612025Jan 2025: 65Feb 2025: 46Mar 2025: 45Apr 2025: 82May 2025: 67Jun 2025: 69Jul 2025: 58Aug 2025: 84Sep 2025: 81Oct 2025: 105Nov 2025: 61Dec 2025: 712026Jan 2026: 75Feb 2026: 54Mar 2026: 72Apr 2026: 102May 2026: 118Jun 2026: 133Jul 2026: 104Aug 2026: 100

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

04178342019: 29620192020: 37020202021: 37320212022: 67320222023: 58220232024: 75020242025: 83420252026: 7582026

Event type and report source

Event type, as classified on the report

Death0%0
Injury97.7%4,529
Malfunction2.3%107
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%4,636
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 231,877 reports carrying product code FTR. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Device appears to trigger rejection2,78160%21.6%
Material rupture62613.5%42.7%
Patient-device incompatibilitythe device did not suit the patient53811.6%6.6%
Malposition of device1633.5%0.5%
Migrationthe device moved from where it was placed1172.5%2.4%
Difficult to open or remove packaging material721.6%0.1%
Device handling problem310.7%0.2%
Breakthe device broke190.4%0.5%
Device contaminated during manufacture or shipping130.3%0%
Contamination120.3%0%
Device dislodged or dislocated100.2%0%
Improper or incorrect procedure or method90.2%0.1%
Delivered as unsterile product70.2%0%
Gel leak60.1%1.9%
Device contamination with chemical or other material50.1%0.1%
Material deformation50.1%0.2%
Fluid/blood leak40.1%0.2%
Device damaged prior to usethe device was damaged before use30.1%0%
Material invagination30.1%0%
Biofilm coating in device20%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Capsular contracturescar tissue tightening around an implant3,23069.7%
Failure of implant62713.5%
Seromaa collection of fluid under the skin1092.4%
Appropriate clinical signs, symptoms and conditions term/code not available761.6%
Wound dehiscencea wound reopened741.6%
Foreign body reaction561.2%
Impaired healingslow healing400.9%
Necrosisdeath of tissue260.6%
Cellulitisa skin infection210.5%
Hematomaa collection of blood under the skin or in tissue210.5%
Foreign body sensation in eye190.4%
Painpain, site not specified140.3%
Deformity/ disfigurement110.2%
Abscessa collection of pus90.2%
Erosion90.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureInspira Smooth Cohesive Silicone Gel Filled Breast ImplantProduct code FTRAll MAUDE reports
Reports4,636231,87726,136,888
Share of that pool—2%0%
Classified as death, per 1,000 reports019
Classified as injury97.7%97.7%36.2%
Classified as malfunction2.3%1.6%62.3%
Filed by the manufacturer100%95%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code FTR

BrandReportsLatest 12 monthsClassified as death
MENTOR MemoryGel Breast Implant57,7717,7080%
Inspira Smooth Silicone Gel Filled Breast Implant35,6346,7820%
Inspira Textured Silicone Gel Filled Breast Implant24,7952,7660%
Style 410 Cohesive Silicone Gel Filled Breast Implant15,2871,8410.1%
Style 15 Silicone Gel Filled Breast Implant9,5671,5290.1%
Style 20 Silicone Gel Filled Breast Implant6,3689810.1%
Sientra Silicone Gel Breast Implants6,0141,6820%
Style 115 Silicone Gel Filled Breast Implant5,7105460%
Unknown Gel Implants5,3377030%
UNK Gel Breast Implant5,3027820.4%
MENTOR MemoryGel Xtra Breast Implant4,9101,3870%
Sientra Opus Silicone Gel Breast Implant4,61300%
Style 110 Silicone Gel Filled Breast Implant3,3642790%
Style 10 Silicone Gel Filled Breast Implant3,3534790.1%
Style 120 Silicone Gel Filled Breast Implant2,8812120.1%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Inspira Smooth Cohesive Silicone Gel Filled Breast Implant reports

How many FDA reports name Inspira Smooth Cohesive Silicone Gel Filled Breast Implant?

4,636 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,076 in the latest 12 months.

What kinds of events are reported?

injury (97.7%) and malfunction (2.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

device appears to trigger rejection (60%), material rupture (13.5%), patient-device incompatibility (11.6%), malposition of device (3.5%) and migration (2.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Inspira Smooth Cohesive Silicone Gel Filled Breast Implant was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.